Skip to content

Drug interactions

Lapatinib + Sofosbuvir-velpatasvir

Severity: Moderate

Lapatinib and Sofosbuvir-velpatasvir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Velpatasvir may increase lapatinib exposure through inhibition of efflux transporters. Higher lapatinib levels raise the risk of diarrhea, hepatotoxicity and QT prolongation.

What this interaction means in plain words

Lapatinib and Sofosbuvir-velpatasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lapatinib belongs to Oncology; Sofosbuvir-velpatasvir belongs to Anti Virals.

Evidence level: Low

Why it happens

Velpatasvir inhibits BCRP and P-gp, which may increase lapatinib absorption and reduce its efflux.

What to do

Monitor liver tests and for diarrhea, and consider ECG monitoring where QT risk is present. Reduce the lapatinib dose if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Sofosbuvir-velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Sofosbuvir-velpatasvir?

MediHelp rates the interaction as moderate. Lapatinib and Sofosbuvir-velpatasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Velpatasvir may increase lapatinib exposure through inhibition of efflux transporters. Higher lapatinib levels raise the risk of diarrhea, hepatotoxicity and QT prolongation.

How serious is the interaction between Lapatinib and Sofosbuvir-velpatasvir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver tests and for diarrhea, and consider ECG monitoring where QT risk is present. Reduce the lapatinib dose if toxicity develops.

What other medicines interact with Sofosbuvir-velpatasvir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir with, for example, Rifampin, Rifapentine, St john's wort. The full list is on the Sofosbuvir-velpatasvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in